Organism name | Arnica longifolia |
---|---|
Genus | Arnica |
Family | Asteraceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Arnica longifolia |
---|---|
Linked NCBI taxonomy ID | 149410 |
Linked level | species |
Family in NCBI taxonomy | Asteraceae |
---|---|
ID | 4210 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | asterids |
---|---|
ID | 71274 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00003894
![]() |
Eupatorin
/ 3',5-Dihydroxy-4',6,7-trimethoxyflavone / 5-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)-6,7-dimethoxy-4H-1-benzopyran-4-one |
CHEMBL487402
|
C103110
|
5 / 5 / 4 | 5 / 0 | No. 3 | No. 15 |
![]() |
C00003865
![]() |
7-O-Methylluteolin
/ Luteolin 7-methyl ether / 5,3',4'-Trihydroxy-7-methoxyflavone / 2-(3,4-Dihydroxyphenyl)-5-hydroxy-7-methoxy-4H-1-benzopyran-4-one |
CHEMBL183745
|
C051414
|
1 / 1 / 2 | No. 3 | No. 15 |
![]() |
|
C00003891
![]() |
Demethoxycentaureidin
/ Desmethoxycentaureidin / 5,7,3'-Trihydroxy-6,4'-dimethoxyflavone / 5,7-Dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-6-methoxy-4H-1-benzopyran-4-one |
CHEMBL74838
|
No. 3 | No. 15 |
![]() |
|||
C00004697
![]() |
Veronicafolin
|
No. 3 | No. 15 |
![]() |
||||
C00020346
![]() |
Carabrone
/ Caropesia lactone |
No. 144 | No. 38 |
![]() |
||||
C00003298
![]() |
Helenalin
|
CHEMBL338474
CHEMBL354946 CHEMBL486996 CHEMBL1728820 CHEMBL1911137 |
C001329
|
37 / 36 / 29 | 18 / 3 | No. 495 | No. 38 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
Q16637 | Survival motor neuron protein | Unclassified protein | C00003298 | 4 / 1 |
P17861 | X-box-binding protein 1 | Unclassified protein | C00003298 | 1 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | C00003298 | 1 / 1 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00003298 | 2 / 0 |
P00747 | Plasminogen | S1A | C00003865 | 1 / 2 |
P06746 | DNA polymerase beta | Enzyme | C00003298 | 0 / 0 |
P04062 | Glucosylceramidase | Enzyme | C00003298 | 6 / 4 |
O14965 | Aurora kinase A | Aur | C00003894 | 0 / 0 |
Q9Y5X4 | Photoreceptor-specific nuclear receptor | NR2E3 | C00003298 | 2 / 2 |
P30556 | Type-1 angiotensin II receptor | Angiotensin receptor | C00003298 | 1 / 1 |
P04798 | Cytochrome P450 1A1 | Cytochrome P450 1A1 | C00003894 | 0 / 0 |
P11473 | Vitamin D3 receptor | NR1I1 | C00003298 | 2 / 3 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00003298 | 0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00003298 | 0 / 0 |
P42858 | Huntingtin | Unclassified protein | C00003298 | 1 / 1 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00003298 | 2 / 0 |
O75496 | Geminin | Unclassified protein | C00003298 | 0 / 0 |
P51151 | Ras-related protein Rab-9A | Unclassified protein | C00003298 | 0 / 0 |
P38398 | Breast cancer type 1 susceptibility protein | Enzyme | C00003298 | 4 / 2 |
Q9Y2T6 | G-protein coupled receptor 55 | Lysophosphatidylinositol receptor | C00003298 | 0 / 0 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00003298 | 0 / 0 |
Q04206 | Transcription factor p65 | Transcription Factor | C00003298 | 0 / 0 |
Q9Y253 | DNA polymerase eta | Enzyme | C00003298 | 1 / 1 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00003298 | 0 / 0 |
Q9HC16 | DNA dC->dU-editing enzyme APOBEC-3G | Enzyme | C00003298 | 0 / 0 |
Q16678 | Cytochrome P450 1B1 | Cytochrome P450 1B1 | C00003894 | 4 / 4 |
P06280 | Alpha-galactosidase A | Enzyme | C00003298 | 1 / 1 |
Q96GD4 | Aurora kinase B | Aur | C00003894 | 0 / 0 |
P35968 | Vascular endothelial growth factor receptor 2 | Vegfr | C00003894 | 1 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00003298 | 0 / 0 |
Q00987 | E3 ubiquitin-protein ligase Mdm2 | Other nuclear protein | C00003298 | 1 / 5 |
O15118 | Niemann-Pick C1 protein | Unclassified protein | C00003298 | 1 / 1 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00003298 | 0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00003298 | 0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00003298 | 4 / 3 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00003298 | 0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00003298 | 0 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00003298 | 1 / 1 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00003298 | 1 / 0 |
Q8IUX4 | DNA dC->dU-editing enzyme APOBEC-3F | Enzyme | C00003298 | 0 / 0 |
Q00653 | Nuclear factor NF-kappa-B p100 subunit | Transcription Factor | C00003298 | 0 / 0 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00003298 | 0 / 0 |
P01215 | Glycoprotein hormones alpha chain | Unclassified protein | C00003298 | 0 / 3 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
468 | ATF4, CREB-2, CREB2, TAXREB67, TXREB | activating transcription factor 4 |
C00003298
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00003298
|
841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00003298
|
958 | CD40, Bp50, CDW40, TNFRSF5, p50 | CD40 molecule, TNF receptor superfamily member 5 |
C00003298
|
941 | CD80, B7, B7-1, B7.1, BB1, CD28LG, CD28LG1, LAB7 | CD80 molecule |
C00003298
|
9308 | CD83, BL11, HB15 | CD83 molecule |
C00003298
|
942 | CD86, B7-2, B7.2, B70, CD28LG2, LAB72 | CD86 molecule |
C00003298
|
1649 | DDIT3, CEBPZ, CHOP, CHOP-10, CHOP10, GADD153 | DNA-damage-inducible transcript 3 |
C00003298
|
54541 | DDIT4, Dig2, REDD-1, REDD1 | DNA-damage-inducible transcript 4 |
C00003298
|
3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00003298
|
3586 | IL10, CSIF, GVHDS, IL-10, IL10A, TGIF | interleukin 10 |
C00003298
|
3592 | IL12A, CLMF, IL-12A, NFSK, NKSF1, P35 | interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) |
C00003298
|
3593 | IL12B, CLMF, CLMF2, IL-12B, NKSF, NKSF2 | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) |
C00003298
|
3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00003298
|
4792 | NFKBIA, IKBA, MAD-3, NFKBI | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
C00003298
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00003298
|
6648 | SOD2, IPOB, MNSOD, MVCD6 | superoxide dismutase 2, mitochondrial (EC:1.15.1.1) |
C00003298
|
8797 | TNFRSF10A, APO2, CD261, DR4, TRAILR-1, TRAILR1 | tumor necrosis factor receptor superfamily, member 10a |
C00003298
|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00003894
|
1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00003894
|
1557 | CYP2C19, CPCJ, CYP2C, P450C2C, P450IIC19 | cytochrome P450, family 2, subfamily C, polypeptide 19 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00003894
|
1565 | CYP2D6, CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, CYPIID6, P450-DB1, P450C2D, P450DB1 | cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) |
C00003894
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00003894
|
OMIM | preferred title | UniProt |
---|---|---|
#614401 | Accelerated tumor formation, susceptibility to; actfs |
Q00987
|
#114480 | Breast cancer |
P38398
|
#604370 | Breast-ovarian cancer, familial, susceptibility to, 1; brovca1 |
P38398
|
#114500 | Colorectal cancer; crc |
P84022
|
#268100 | Enhanced s-cone syndrome; escs |
Q9Y5X4
|
#301500 | Fabry disease |
P06280
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#608013 | Gaucher disease, perinatal lethal |
P04062
|
#230800 | Gaucher disease, type i |
P04062
|
#230900 | Gaucher disease, type ii |
P04062
|
#231000 | Gaucher disease, type iii |
P04062
|
#231005 | Gaucher disease, type iiic |
P04062
|
#137750 | Glaucoma 1, open angle, a; glc1a |
Q16678
|
#231300 | Glaucoma 3, primary congenital, a; glc3a |
Q16678
|
#137760 | Glaucoma, primary open angle; poag |
Q16678
|
#137800 | Glioma susceptibility 1; glm1 |
O75874
|
#602089 | Hemangioma, capillary infantile |
P35968
|
#143100 | Huntington disease; hd |
P42858
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#612371 | Major affective disorder 7; mafd7 |
P17861
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#257220 | Niemann-pick disease, type c1; npc1 |
O15118
|
#167000 | Ovarian cancer |
P38398
|
#614320 | Pancreatic cancer, susceptibility to, 4; pnca4 |
P38398
|
#168600 | Parkinson disease, late-onset; pd |
P04062
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#604229 | Peters anomaly |
Q16678
|
#172700 | Pick disease of brain |
P10636
|
#217090 | Plasminogen deficiency, type i |
P00747
|
#267430 | Renal tubular dysgenesis; rtd |
P30556
|
#611131 | Retinitis pigmentosa 37; rp37 |
Q9Y5X4
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
KEGG | name | UniProt |
---|---|---|
H00136 | Niemann-Pick disease type C (NPC) |
O15118
(related)
|
H00223 | Inherited thrombophilia |
P00747
(related)
|
H01206 | Plasminogen deficiency |
P00747
(related)
|
H00081 | Hashimoto's thyroiditis |
P01215
(marker)
|
H00082 | Graves' disease |
P01215
(marker)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P01215
(marker)
|
H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
H00126 | Gaucher disease |
P04062
(related)
|
H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
H00125 | Fabry disease |
P06280
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H00575 | Renal tubular dysgenesis |
P30556
(related)
|
H00027 | Ovarian cancer |
P38398
(related)
|
H00031 | Breast cancer |
P38398
(related)
|
H00059 | Huntington's disease (HD) |
P42858
(related)
|
H00025 | Penile cancer |
Q00987
(related)
|
H00028 | Choriocarcinoma |
Q00987
(related)
|
H00036 | Osteosarcoma |
Q00987
(related)
|
H00037 | Alveolar rhabdomyosarcoma |
Q00987
(related)
|
H00042 | Glioma |
Q00987
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00612 | Primary open angle glaucoma |
Q16678
(related)
|
H01075 | Peters anomaly |
Q16678
(related)
|
H01159 | Anterior segment dysgenesis (ASD) |
Q16678
(related)
|
H01203 | Primary congenital glaucoma (PCG) |
Q16678
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
H00527 | Retinitis pigmentosa (RP) |
Q9Y5X4
(related)
|
H00805 | Vitreoretinal degeneration |
Q9Y5X4
(related)
|